Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday

Charles River Laboratories International, Inc. CRL	0.00	0.00%
CSX Corporation CSX	0.00	0.00%
Delta Air Lines, Inc. DAL	0.00	0.00%
Edgewise Therapeutics, Inc. EWTX	0.00	0.00%
Glaukos Corp GKOS	0.00	0.00%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Baird raised the price target for Ryder System Inc (NYSE:R) from $253 to $290. Baird analyst Dan Moore maintained an Outperform rating. Ryder shares closed at $274.66 on Tuesday. See how other analysts view this stock.
BTIG cut Velocity Financial Inc (NYSE:VEL) price target from $23 to $22. BTIG analyst Douglas Harter maintained a Buy rating. Velocity Financial shares closed at $17.74 on Tuesday. See how other analysts view this stock.
Baird raised price target for J B Hunt Transport Services Inc (NASDAQ:JBHT) from $275 to $290. Baird analyst Daniel Moore maintained an Outperform rating. J B Hunt shares closed at $279.82 on Tuesday. See how other analysts view this stock.
Needham increased the price target for Glaukos Corp (NYSE:GKOS) from $136 to $150. Needham analyst David Saxon maintained a Buy rating. Glaukos shares closed at $127.53 on Tuesday. See how other analysts view this stock.
B of A Securities raised CSX Corp (NASDAQ:CSX) price target from $51 to $53. B of A Securities analyst Ken Hoexter maintained a Buy rating. CSX shares closed at $46.90 on Tuesday. See how other analysts view this stock.
Morgan Stanley raised Charles River Lbrtrs ntrntl Inc (NYSE:CRL) price target from $185 to $220. Morgan Stanley analyst Ricky Goldwasser upgraded the stock from Equal-Weight to Overweight. Charles River shares closed at $184.79 on Tuesday. See how other analysts view this stock.
Bernstein raised Delta Air Lines Inc (NYSE:DAL) price target from $88 to $93. Bernstein analyst David Vernon maintained an Outperform rating. Delta Air shares closed at $83.14 on Tuesday. See how other analysts view this stock.
Morgan Stanley cut the price target for Resmed Inc (NYSE:RMD) from $286 to $230. Morgan Stanley analyst David Bailey downgraded the stock from Overweight to Equal-Weight. Resmed shares closed at $193.94 on Tuesday. See how other analysts view this stock.
Goldman Sachs increased Edgewise Therapeutics Inc (NASDAQ:EWTX) price target from $20 to $32. Goldman Sachs analyst Paul Choi maintained a Neutral rating. Edgewise Therapeutics shares closed at $33.95 on Tuesday. See how other analysts view this stock.
Morgan Stanley slashed Iqvia Holdings Inc (NYSE:IQV) price target from $225 to $200. Morgan Stanley analyst Kallum Titchmarsh downgraded the stock from Overweight to Equal-Weight. Iqvia shares closed at $179.17 on Tuesday. See how other analysts view this stock.

Considering buying DAL stock? Here’s what analysts think:

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.